The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...
The stability of ribonucleoprotein complexes of SARS-CoV-2 nucleocapsid proteins differs among variants of concern and the viral evolution of nucleocapsid protein can be understood in the framework of ...
The following is a summary of “Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination,” published in the March 2025 ...
Data provided to U.S. FDA, with update to PEMGARDA Fact Sheet for Healthcare Providers anticipated WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced ...
This study provides important insights into how IL-1 cytokines protect cells against SARS-CoV-2 infection. By inducing a non-canonical RhoA/ROCK signaling pathway, IL-1beta inhibits the ability of ...
Exosomes, which are small extracellular vesicles, are of particular interest in studies on SARS-CoV-2 infection because of their crucial role in intercellular communication. These vesicles are ...
ABSTRACT: This study utilizes the enzyme-substrate complex theory to predict the clinical efficacy of COVID-19 treatments at the biological systems level, using molecular docking stability indicators.
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. The 2019 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...
It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results